Tickerplace logo

Tickerplace

Harvard Bioscience, Inc. logo

HBIOHarvard Bioscience, Inc.

HBIO Stock Price, Valuation & Chart | Harvard Bioscience, Inc.

Compare
$8.090-0.22 (-2.65%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Instruments & Supplies
OverviewFinancialsDividendsRatios

HBIO Historical price chart

HBIO Key Stats

Market Capitalization36.83M
PE Ratio-22.47
EPS-0.36
Trading Volume20.08K
Today's High/Low8.35/7.99
Dividend Yield0.00
52 Week High/Low9.4/3.76
Shares Outstanding4.55M
HBIO Financial Statement
HBIO Analyst ratings
HBIO Analysis & performance metrics

HBIO Company profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for…

HBIO Management team

Management
John J. Fry J.D.
Chief Legal Counsel & Corporation Secretary
Ryan Wallace
Senior Vice President of Global Sales
Lori Packer
Vice President of Global People Operations
Kathryn Flynn
Corporate Controller
James W. GreenCEO
President, Chief Executive Officer & Chairman
Mark T. FrostCFO
Interim Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer
David SiroisCTO
Director of Corporate Accounting & SEC Reporting
Total 7 executives

HBIO Frequently asked questions

What is Harvard Bioscience, Inc. (HBIO) Stock Price?

Current stock price of Harvard Bioscience, Inc. (HBIO) stock is $8.090. The stock price is -2.65% lower in the session. The intraday range can be seen from this page. Volume of Harvard Bioscience, Inc. (HBIO) stock is 20.08K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Harvard Bioscience, Inc. (HBIO) stock price going up or down today?

The stock price of Harvard Bioscience, Inc. (HBIO) can change with earnings, company news, and overall market sentiment. Harvard Bioscience, Inc. operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Harvard Bioscience, Inc. stock expensive at its current price?

Whether Harvard Bioscience, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HBIO on this page is -22.47. EPS on this page is -0.36. Compare those figures with peers and growth expectations before deciding if the current Harvard Bioscience, Inc. price is justified.

How has the stock price of Harvard Bioscience, Inc. (HBIO) performed historically?

Historical performance for Harvard Bioscience, Inc. (HBIO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HBIO reacted to past earnings and market events.

Should I buy Harvard Bioscience, Inc. (HBIO) stock, at this price?

Buying Harvard Bioscience, Inc. (HBIO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.